Jay Graham, BS Pharm, PharmD, RPh

RBP-7000 for the Treatment of Schizophrenia: Efficacy and Safety Results From Two Phase III Trials

Introduction: RBP-7000 is a subcutaneously administered, once-monthly, extended-release depot formulation of risperidone designed to achieve therapeutic concentrations without supplementa...

Anne Andorn , MD;

Maurizio Fava , MD, PhD;

John Newcomer , MD;

Sunita Shinde , MD;

Gilbert Muma , PhD;

Christian Heidbreder , PhD;

Jay Graham , BS Pharm, PharmD, RPh;

03/01/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Jay Graham, BS Pharm, PharmD, RPh

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products